Image Analysis: A Vital Tool for Drug Discovery

Image Analysis: A Vital Tool for Drug Discovery
An interview with Amanda Lowe, Senior Vice President and Andreas Schønau, Chief Scientific Officer of Visiopharm, a solution provider company at the marcus evans Discovery Summit 2015, on how quantitative digital pathology can enhance the drug disc...
Read more

Cancer Biomarker Assessment and Tumor Heterogeneity

Cancer Biomarker Assessment and Tumor Heterogeneity
Tumor Heterogeneity Scientists increasingly believe that the development of new and more efficient treatments will require a deeper understanding of (intra) tumoral heterogeneity. Pursuing this important goal, will require new and sophisticated too...
Read more

Aalborg University Hospital Selects Visiopharm for Cancer Diagnostics

Aalborg University Hospital Selects Visiopharm for Cancer Diagnostics
Visiopharm releases Oncotopix™ Diagnostics – a solution for computer assisted in-vitro diagnostics, including quantitative diagnostic immunohistochemistry (IHC) and In-Situ Hybridization (ISH). “Institute of pathology, Aalborg University Hospit...
Read more